General Information of Drug (ID: DME47TX)

Drug Name
RG7112 Drug Info
Synonyms
RO5045337; QBGKPEROWUKSBK-QPPIDDCLSA-N; 939981-39-2; UNII-Q8MI0X869M; Q8MI0X869M; RO-5045337; CHEMBL2386346; Ro 5045337; GTPL9599; SCHEMBL12704861; DTXSID60240182; MolPort-044-560-282; EX-A1686; s7030; ZINC96270381; BDBM50434287; AKOS027282701; CS-0330; HY-10959; RG7112 (RO5045337); [(4s,5r)-2-(4-t-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone; Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]
Cross-matching ID
PubChem CID
57406853
ChEBI ID
CHEMBL2386346
CAS Number
CAS 939981-39-2
TTD Drug ID
D08EOW

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Protein processing in endoplasmic reticulum 2.45 0.00e+0 127/171 (74.27%) EIF2AK3;P4HB;HERPUD1;...
Protein export 1.97 0.00e+0 17/23 (73.91%) SEC61A1;SEC63;SEC62;...
Autophagy 1.95 0.00e+0 113/169 (66.86%) DDIT4;EIF2AK3;RAB1A;...
Complement and coagulation cascades 1.95 0.00e+0 76/85 (89.41%) CFD;SERPINA5;FGB;...
Insulin resistance 1.92 3.10e-3 96/108 (88.89%) GFPT1;CREB3L2;PCK2;...
Ferroptosis 1.92 2.58e-3 36/41 (87.8%) SLC39A14;TF;HMOX1;...
Thyroid hormone synthesis 1.91 2.21e-3 66/75 (88%) PDIA4;ALB;PLCB1;...
Fat digestion and absorption 1.89 1.93e-3 35/43 (81.4%) SCARB1;PLPP3;CD36;...
ErbB signaling pathway 1.88 5.16e-3 79/85 (92.94%) CDKN1A;EREG;MYC;...
Glycosaminoglycan biosynthesis 1.85 6.19e-3 40/58 (68.97%) DSE;FUT8;CHPF;...
Metabolism of xenobiotics by cytochrome P450 1.83 1.13e-2 49/77 (63.64%) GSTM3;GSTA1;EPHX1;...
Lysosome 1.81 1.29e-2 115/128 (89.84%) CTSH;CTSG;CD164;...
Cholesterol metabolism 1.80 1.43e-2 44/50 (88%) LRPAP1;SCARB1;CD36;...
Various types of N-glycan biosynthesis 1.79 1.55e-2 26/39 (66.67%) MGAT2;FUT8;HEXA;...
N-Glycan biosynthesis 1.77 1.86e-2 38/50 (76%) MGAT2;FUT8;ALG5;...
Vitamin digestion and absorption 1.76 2.03e-2 17/24 (70.83%) SCARB1;SLC19A2;APOA1;...
Cortisol synthesis and secretion 1.73 2.64e-2 58/65 (89.23%) PLCB1;ADCY9;CREB3L2;...
Other glycan degradation 1.71 3.35e-2 13/18 (72.22%) FUCA1;HEXA;NEU1;...
Steroid biosynthesis 1.70 3.58e-2 19/20 (95%) SQLE;SC5D;HSD17B7;...
Insulin signaling pathway 1.69 3.79e-2 121/137 (88.32%) INPP5A;PCK2;RPS6KB1;...
Phenylalanine metabolism 1.68 3.68e-2 14/17 (82.35%) MAOA;HPD;PAH;...
Aldosterone synthesis and secretion 1.68 3.73e-2 85/98 (86.73%) ATP2B1;PLCB1;ADCY9;...
Sphingolipid metabolism 1.68 3.70e-2 32/49 (65.31%) DEGS1;PLPP3;NEU1;...
Parathyroid hormone synthesis, secretion and action 1.65 4.71e-2 98/106 (92.45%) CDKN1A;PLCB1;ADCY9;...
Base excision repair -1.63 3.88e-2 29/33 (87.88%) PARP1;POLD3;POLB;...
Progesterone-mediated oocyte maturation -1.71 1.99e-2 75/100 (75%) ANAPC10;CDC23;ARAF;...
Oocyte meiosis -1.83 6.85e-3 90/129 (69.77%) PLK1;MAPK13;CDC25C;...
Non-homologous end-joining -1.83 7.71e-3 11/13 (84.62%) RAD50;MRE11;DNTT;...
Spliceosome -1.97 0.00e+0 101/150 (67.33%) SF3B4;PRPF8;SNRPC;...
Fanconi anemia pathway -2.07 0.00e+0 36/54 (66.67%) CENPX;FANCC;FANCE;...
Nucleotide excision repair -2.16 0.00e+0 40/47 (85.11%) POLD1;RPA1;LIG1;...
Mismatch repair -2.23 0.00e+0 22/23 (95.65%) POLD3;MLH3;SSBP1;...
Homologous recombination -2.24 0.00e+0 35/41 (85.37%) POLD3;RAD54L;TOPBP1;...
Cell cycle -2.46 0.00e+0 110/124 (88.71%) RBL1;PLK1;CDKN2A;...
DNA replication -2.68 0.00e+0 34/36 (94.44%) POLE;SSBP1;PCNA;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 3.33uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 3.33uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
NCI-H838 CVCL_1594 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 1.11uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H